Alumis Inc. Common Stock
Alumis Inc. Common Stock (ALMS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
alms · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Alumis Inc. Common Stock (ALMS) measures how much investors pay for each dollar of the company's trailing earnings. ALMS's current PE ratio of N/A is calculated by dividing its stock price of $19.06 by its TTM earnings per share of -$1.90.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2022 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Alumis Inc. Common StockYou ALMS | $2.4B | N/A | — | -$1.90 |
 ADC Therapeutics S.A. ADCT | $114M | N/A | — | -$1.12 |
 Bicycle Therapeutics plc BCYC | $284M | N/A | — | -$3.16 |
 Eton Pharmaceuticals, Inc. ETON | $792M | N/A | — | -$0.17 |
 Fulcrum Therapeutics, Inc. FULC | $186M | N/A | — | -$1.18 |
 Lineage Cell Therapeutics, Inc. LCTX | $302M | N/A | — | -$0.28 |
 Lexicon Pharmaceuticals, Inc. LXRX | $842M | N/A | — | -$0.14 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.29 | — | |
2024-12-31 FY2024 | — | $-10.38 | — | |
2023-12-31 FY2023 | — | $-2.99 | — | |
2022-12-31 FY2022 | — | $-14.93 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Alumis Inc. Common Stock (ALMS) measures how much investors pay for each dollar of the company's trailing earnings. ALMS's current PE ratio of N/A is calculated by dividing its stock price of $19.06 by its TTM earnings per share of -$1.90.
Frequently asked questions
ALMS pe ratio · 6 questionsALMS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $19.06 and TTM EPS of -$1.90. Data sourced from Financial Modeling Prep via ALMS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Alumis Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08